Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol
- 533 Downloads
This study investigated the therapeutic efficiency of monomethoxy polyethylene glycol-poly(lactic-co-glycolic acid) (mPEG-PLGA) co-loaded with syringopicroside and hydroxytyrosol as a drug with effective targeting and loading capacity as well as persistent circulation in vivo. The nanoparticles were prepared using a nanoprecipitation method with mPEG-PLGA as nano-carrier co-loaded with syringopicroside and hydroxytyrosol (SH-NPs). The parameters like in vivo pharmacokinetics, biodistribution in vivo, fluorescence in vivo endomicroscopy, and cellular uptake of SH-NPs were investigated. Results showed that the total encapsulation efficiency was 32.38 ± 2.76 %. Total drug loading was 12.01 ± 0.42 %, particle size was 91.70 ± 2.11 nm, polydispersity index was 0.22 ± 0.01, and zeta potential was −24.5 ± 1.16 mV for the optimized SH-NPs. The nanoparticle morphology was characterized using transmission electron microscopy, which indicated that the particles of SH-NPs were in uniformity within the nanosize range and of spherical core shell morphology. Drug release followed Higuchi kinetics. Compared with syringopicroside and hydroxytyrosol mixture (SH), SH-NPs produced drug concentrations that persisted for a significantly longer time in plasma following second-order kinetics. The nanoparticles moved gradually into the cell, thereby increasing the quantity. ALT, AST, and MDA levels were significantly lower on exposure to SH-NPs than in controls. SH-NPs could inhibit the proliferation of HepG2.2.15 cells and could be taken up by HepG2.2.15 cells. The results confirmed that syringopicroside and hydroxytyrosol can be loaded simultaneously into mPEG-PLGA nanoparticles. Using mPEG-PLGA as nano-carrier, sustained release, high distribution in the liver, and protective effects against hepatic injury were observed in comparison to SH.
KeywordsDrug Release Zeta Potential Cellular Uptake Drug Loading Entrapment Efficiency
Syringopicroside and hydroxytyrosol
Nanoparticles co-loaded with syringopicroside and hydroxytyrosol
- t1/2 α
Alpha elimination half-life
- t1/2 β
Beta elimination half-life
Area under the concentration–time curve
We acknowledge Specialized Research Fund for the Doctoral Program of Higher Education (20112327110009) and the National Natural Science Foundation of China (81274091) for the Grants received in support of this research.
Compliance with ethical standards
The authors report no conflicts of interest in this work.
- 1.Wang F, Wen YJ, Niu JQ, Jiang WC, Xu C, Cai Z. Experimental studies of the phamacologic and toxical effects of the dingxiangye tablet. Chin J Clin Hepatol. 2000;14:94–6.Google Scholar
- 2.Fang J, Zhang XW, Li YJ, Wang YH, Wamg LM. Experimental study on Syringopicroside anti duck hepatitis B virus. Inf Tradit Chin Med. 2011;28:133–4.Google Scholar
- 10.Deng L, Sun D, Zhang Y, Huo J, Yuan Y, Dong A. Studies on paclitaxel-loaded methoxy poly (ethylene glycol)/poly (l-lactic acid) diblock copolymer nanoparticles. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2005;22(4):715–8.Google Scholar
- 17.Kumar R, Kulkarni A, Nabulsi J, Nagesha DK, Cormack R, Makrigiorgos MG, et al. Facile synthesis of PEGylated PLGA nanoparticles encapsulating doxorubicin and its in vitro evaluation as potent drug delivery vehicle. Drug Deliv Transl Res. 2013;3(4):299–308. doi: 10.1007/s13346-012-0124-9.CrossRefGoogle Scholar
- 18.Yuan Y, Sun YN, Lu CH. Study on the biological characteristics and mechanism of nanometer drugs. China Pharmacol Bull. 2013;29:1180–4.Google Scholar
- 25.Li T, Yan Z, Zhou C, Sun J, Jiang C, Yang X. Simultaneous quantification of paeoniflorin, nobiletin, tangeretin, liquiritigenin, isoliquiritigenin, liquiritin and formononetin from Si-Ni-San extract in rat plasma and tissues by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2013;27(8):1041–53. doi: 10.1002/bmc.2904.Google Scholar
- 30.Mahmoud MF, Hamdan DI, Wink M, El-Shazly AM. Hepatoprotective effect of limonin, a natural limonoid from the seed of Citrus aurantium var. bigaradia, on D-galactosamine-induced liver injury in rats. Naunyn Schmiedebergs Arch Pharmacol. 2014;387(3):251–61. doi: 10.1007/s00210-013-0937-1.CrossRefGoogle Scholar